Anzeige
Mehr »
Montag, 30.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Dow Jones News
815 Leser
Artikel bewerten:
(2)

RUBIS: Minutes of the CSM of 9 June 2022: approval of all resolutions and business update

DJ RUBIS: Minutes of the CSM of 9 June 2022: approval of all resolutions and business update

RUBIS RUBIS: Minutes of the CSM of 9 June 2022: approval of all resolutions and business update 09-Jun-2022 / 17:45 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.

-----------------------------------------------------------------------------------------------------------------------

Paris, 9 June 2022, 5.45 p.m.

MINUTES OF THE CSM OF 9 JUNE 2022:

APPROVAL OF ALL RESOLUTIONS AND BUSINESS UPDATE

The Combined Shareholders' Meeting of Rubis was held on Thursday 9 June 2022, at 2.00 p.m. at Salons Hoche, 9 avenue Hoche, 75008 Paris, France. It was chaired by M. Gilles Gobin.

This Shareholders' Meeting was webcast live on the Company's website (www.rubis.fr/en) and remains available for replay on this website and via the following link https://channel.royalcast.com/rubisen/#!/rubisen/20220609_1.

The highlights, the strategy, the business in 2021 and the CSR approach were presented to shareholders by the Management. Management reiterated its vision of the Group's development over the medium/long term. Bruno Krief (Chief Financial Officer) added: "The first quarter of 2022 has started well with a gross profit up 7% in Retail & Marketing and up 19% in supply/shipping (sub-segment of Support & Services). The beginning of the second quarter is in line with the progress observed in Q1, pointing to a good development in operating results (at constant perimeter) overall for the first half of the year. Afterwards, the Chairman of the Supervisory Board then described the Company's governance. Finally, the Statutory Auditors presented their reports.

No written question has been sent to the Company by shareholders beforehand. Following a questions and answers session with shareholders attending physically the meeting, the resolutions were submitted to shareholders' vote.

Shareholders approved all the resolutions, and in particular:

-- the statutory and consolidated financial statements for FY 2021;

-- the payment of a dividend of EUR1.86 per ordinary share and EUR0.93 per preference share (the ex-dividenddate is 14 June 2022 and the dividend will be paid in cash on 16 June 2022);

-- the renewal of Carole Fiquemont's, Chantal Mazzacurati's and Marc-Olivier Laurent's terms of office asSupervisory Board members;

-- the appointment of Cécile Maisonneuve, Carine Vinardi and Alberto Pedrosa as Supervisory Board members;

-- the appointment of KPMG SA as Statutory Auditor;

-- the compensation paid during or awarded in respect of FY 2021 to the corporate officers;

-- the compensation policies applicable to the corporate officers for FY 2022;

-- the tacit renewal of a related-party agreement already approved by the 2021 Shareholders' Meeting;

-- the authorisation granted to the Management Board to carry out a share buyback programme in the frameworkof a liquidity agreement;

-- the authorisation granted to the Management Board to set up performance shares plan(s);

-- the amendment to Article 54 of the by-laws relating to the fixed compensation of the Management Board.

The detailed outcome of the votes will soon be published on the Company's website (www.rubis.fr/en) under the tab "Shareholders - General Meeting - General Meeting June 09, 2022 - Other Documents".

Contact 
       RUBIS - Legal Department 
       Tel: +(33) 1 44 17 95 95 

-----------------------------------------------------------------------------------------------------------------------

Regulatory filing PDF file File: RUBIS: Minutes of the CSM of 9 June 2022: approval of all resolutions and business update

=---------------------------------------------------- 
Language:    English 
Company:     RUBIS 
         46, rue Boissière 
         75116 Paris 
         France 
Phone:      +33 144 17 95 95 
Fax:       +33 145 01 72 49 
E-mail:     investors@rubis.fr 
Internet:    www.rubis.fr 
ISIN:      FR0013269123 
Euronext Ticker: RUI 
AMF Category:  Inside information / Other releases 
EQS News ID:   1371171 
 
End of Announcement EQS News Service 
=------------------------------------------------------------------------------------ 

1371171 09-Jun-2022 CET/CEST

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1371171&application_name=news

(END) Dow Jones Newswires

June 09, 2022 11:45 ET (15:45 GMT)

© 2022 Dow Jones News
Die USA haben fertig! 5 Aktien für den China-Boom
Die Finanzwelt ist im Umbruch! Nach Jahren der Dominanz erschüttert Donald Trumps erratische Wirtschaftspolitik das Fundament des amerikanischen Kapitalismus. Handelskriege, Rekordzölle und politische Isolation haben eine Kapitalflucht historischen Ausmaßes ausgelöst.

Milliarden strömen aus den USA – und suchen neue, lukrative Ziele. Und genau hier kommt China ins Spiel. Trotz aller Spannungen wächst die chinesische Wirtschaft dynamisch weiter, Innovation und Digitalisierung treiben die Märkte an.

Im kostenlosen Spezialreport stellen wir Ihnen 5 Aktien aus China vor, die vom US-Niedergang profitieren und das Potenzial haben, den Markt regelrecht zu überflügeln. Wer jetzt klug investiert, sichert sich den Zugang zu den neuen Wachstums-Champions von morgen.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche 5 Aktien die Konkurrenz aus den USA outperformen dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.